| P2093 | author name string | Josef Thalhamer | |
| | Romana Hochreiter | |
| | Richard Weiss | |
| | Sandra Scheiblhofer | |
| | Arnulf Hartl | |
| P2860 | cites work | Codon usage tabulated from international DNA sequence databases: status for the year 2000 | Q24498251 |
| | CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma | Q24568172 |
| | Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization | Q24599495 |
| | DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction | Q24671114 |
| | Gene vaccination with naked plasmid DNA: mechanism of CTL priming | Q24676957 |
| | DNA vaccines: immunology, application, and optimization* | Q28145651 |
| | Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice | Q28590595 |
| | Tolerance, danger, and the extended family | Q29547532 |
| | The dendritic cell system and its role in immunogenicity | Q29619870 |
| | Receptors and cytokines involved in allergic TH2 cell responses | Q33636119 |
| | Cytotoxic T lymphocyte activation by cross-priming | Q33664714 |
| | The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy | Q33784067 |
| | DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity. | Q34004529 |
| | CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. | Q34300766 |
| | Nucleic acid for the treatment of cancer: genetic vaccines and DNA adjuvants. | Q34373095 |
| | CpG motifs in bacterial DNA and their immune effects | Q34542287 |
| | CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes | Q36375919 |
| | Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. | Q36438020 |
| | Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells | Q37411183 |
| | Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine | Q40811278 |
| | Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 |
| | Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle | Q41607156 |
| | Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. | Q43514345 |
| | Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. | Q43630089 |
| | Heterologous protection against influenza by injection of DNA encoding a viral protein | Q43828996 |
| | Genetic immunization is a simple method for eliciting an immune response | Q43857336 |
| | Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells | Q44401631 |
| | Recombinant fusion peptides containing single or multiple repeats of a ubiquitous T-helper epitope are highly immunogenic | Q44433947 |
| | Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms | Q47850598 |
| | A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell | Q47982760 |
| | Antigen-independent suppression of the allergic immune response to bee venom phospholipase A(2) by DNA vaccination in CBA/J mice. | Q52021757 |
| | Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. | Q52844746 |
| | Involvement of an ATP-Dependent Peptide Chaperone in Cross-Presentation After DNA Immunization | Q56967634 |
| | A Neural Network Method for Identification of Prokaryotic and Eukaryotic Signal Peptides and Prediction of their Cleavage Sites | Q57825167 |
| | Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen | Q60384406 |
| | Isoforms of the Major Allergen of Birch Pollen Induce Different Immune Responses after Genetic Immunization | Q60384415 |
| | DNA Fusion Vaccine Designed to Induce Cytotoxic T Cell Responses Against Defined Peptide Motifs: Implications for Cancer Vaccines | Q62028592 |
| | Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization | Q71046576 |
| | Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus | Q73294601 |
| | Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model | Q73365754 |
| | Genetic immunisation with bovine beta-lactoglobulin cDNA induces a preventive and persistent inhibition of specific anti-BLG IgE response in mice | Q74757459 |
| | Induction of specific Th1 responses and suppression of IgE antibody formation by vaccination with plasmid DNA encoding Der f 11 | Q77800233 |
| | DNA vaccines | Q93896322 |
| P433 | issue | 3 | |
| P304 | page(s) | 328-339 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Methods | Q6823859 |
| P1476 | title | DNA vaccines for allergy treatment | |
| P478 | volume | 32 | |